ExodusPoint Capital Management »

Keros Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $364k 23k 15.82
2025-03-31 $193k 19k 10.17
2022-12-31 $568k 12k 48.04
2021-09-30 $631k 16k 39.56

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ameren Corporation (AEE)
Merck & Co Call Option (MRK)
Nebius Group Shs Class A Put Option (NBIS)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Evergy (EVRG)
Microsoft Corporation Put Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics